Clinical Trial Information

Trial Number: NCT01026220 (
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin Lymphoma
Study ID:
Images are available?:
Is this a NCI-MATCH Trial?:

Datasets Linked to Trial

Title Description
NCT01026220-D1 NCT01026220-D1 Dataset contains all the data which provides all the numbers, statistics, figures and tables in this publication. The data includes patient demographics, clinical characteristics and survival endpoints. This dataset is presented at patient level and includes one record per patient.